Rebecca Mancini

Rebecca Mancini is a seasoned professional in regulatory affairs, currently serving as Vice President and Global Regulatory Strategy Head for Oncology and Precision Medicine at Gilead Sciences since December 2021. Previously, Rebecca held positions including Executive Director of Global Regulatory Affairs for Oncology at Merck, Senior Director of Global Regulatory Affairs at Merck, and various roles at Novartis Oncology, including Director and Senior Associate Director of Regulatory Affairs. The regulatory expertise also extends to Novartis, where Rebecca served as Associate Director and Global Program Regulatory Manager, and GlaxoSmithKline as Regulatory Affairs Manager. Rebecca's career began at Merck with roles ranging from Senior Regulatory Coordinator to Research Biologist. Educational qualifications include a Bachelor of Science in Microbiology from Ohio University and a Master of Science in Molecular Biology from Buffalo State University.